Dysfunctional uterine bleeding.
D000293:Adolescent; D000933:Antifibrinolytic Agents; D003276:Contraceptives, Oral / Q000627:therapeutic use; D004700:Endocrine System Diseases / Q000150:complications; D004717:Endometrium / Q000503:physiopathology; D004958:Estradiol / Q000502:physiology; D004967:Estrogens / Q000502:physiology / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000502:physiology; D006801:Humans; D007031:Hypothalamus / Q000502:physiology; D007986:Luteinizing Hormone / Q000502:physiology; D008208:Lymphatic System / Q000502:physiology; D008598:Menstruation; D008599:Menstruation Disturbances / Q000209:etiology / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D008875:Middle Aged; D010060:Ovulation; D011374:Progesterone / Q000502:physiology / Q000627:therapeutic use; D011453:Prostaglandins / Q000502:physiology
D000933:Antifibrinolytic Agents; D003276:Contraceptives, Oral; D004967:Estrogens; D011453:Prostaglandins; D011374:Progesterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone